bf/NASDAQ:ENLV_icon.jpeg

    COM:ENLIVEX

    Enlivex Therapeutics

    • Stock

    USD

    Last Close

    0.89

    07/04 20:00

    Market Cap

    21.00M

    Beta: -

    Volume Today

    105.67K

    Avg: -

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Dec '14
    Dec '15
    Dec '16
    Dec '17
    Dec '18
    Dec '19
    Dec '20
    Dec '21
    Dec '22
    Dec '23
    asset turnover
    0.06
    -
    cash per share
    34.53
    -
    20.48
    40.69%
    17.28
    15.63%
    8.23
    52.35%
    2.79
    66.17%
    1.39
    50.16%
    2.71
    95.30%
    4.71
    73.73%
    2.62
    44.47%
    1.48
    43.54%
    company equity multiplier
    1.07
    -
    1.14
    6.49%
    1.22
    6.81%
    1.15
    6.26%
    1.14
    0.76%
    1.56
    36.91%
    1.14
    26.93%
    1.12
    1.62%
    1.19
    6.36%
    1.22
    2.88%
    days of inventory outstanding
    days of payables outstanding
    361.50
    -
    days of sales outstanding
    186.59
    -
    dividend yield
    ebit per revenue
    -4.30
    -
    ebt per ebit
    0.99
    -
    0.99
    0.05%
    1.00
    0.50%
    0.99
    0.26%
    0.80
    19.43%
    1.09
    36.00%
    1.21
    10.99%
    0.75
    37.92%
    1.20
    60.51%
    1.17
    3.15%
    effective tax rate
    -0.00
    -
    -0.01
    773.52%
    -0.00
    65.37%
    -0.25
    5,165.60%
    -0.08
    67.28%
    -0.17
    111.53%
    0.33
    293.19%
    -0.37
    209.66%
    enterprise value multiple
    -9.58
    -
    -3.09
    67.72%
    -0.61
    80.23%
    -0.69
    13.26%
    -1.97
    183.95%
    -9.27
    371.66%
    -14.58
    57.27%
    -4.25
    70.84%
    -1.56
    63.35%
    -2.09
    33.89%
    fixed asset turnover
    1.06
    -
    free cash flow per share
    -14.59
    -
    -37.38
    156.16%
    -38.99
    4.31%
    -14.84
    61.94%
    -1.03
    93.04%
    -0.84
    18.97%
    -0.91
    9.19%
    -1.07
    17.52%
    -1.74
    62.48%
    -1.28
    26.64%
    gross profit margin
    1
    -
    interest coverage
    -4.90
    -
    -1.78K
    36,226.50%
    inventory turnover
    long term debt to capitalization
    0.07
    -
    net income per ebt
    1
    -
    1.00
    0.16%
    1.01
    1.21%
    1.00
    0.88%
    1
    0.47%
    1.08
    8.15%
    1.17
    8.41%
    0.67
    43.12%
    1.37
    104.74%
    1
    26.76%
    net profit margin
    -6.09
    -
    operating cash flow per share
    -14.39
    -
    -37.24
    158.88%
    -38.94
    4.57%
    -14.83
    61.91%
    -0.90
    93.93%
    -0.81
    9.63%
    -0.84
    2.68%
    -0.98
    17.52%
    -1.30
    32.57%
    -1.27
    2.74%
    operating profit margin
    -4.30
    -
    payables turnover
    1.01
    -
    pretax profit margin
    -5.19
    -
    price fair value
    2.55
    -
    3.07
    20.25%
    1.90
    38.08%
    2.41
    26.48%
    2.24
    6.95%
    6.43
    187.40%
    3.13
    51.36%
    1.31
    58.04%
    1.28
    2.86%
    1.67
    30.74%
    receivables turnover
    1.96
    -
    return on assets
    -0.21
    -
    -0.75
    251.47%
    -1.51
    101.25%
    -1.64
    8.90%
    -0.38
    76.58%
    -0.58
    50.34%
    -0.34
    40.57%
    -0.10
    70.48%
    -0.63
    518.26%
    -0.79
    25.89%
    return on capital employed
    -0.23
    -
    -0.86
    272.46%
    -1.82
    112.16%
    -1.88
    3.26%
    -0.54
    71.59%
    -0.74
    39.11%
    -0.27
    63.47%
    -0.21
    21.56%
    -0.42
    98.16%
    -0.81
    91.68%
    return on equity
    -0.23
    -
    -0.86
    274.29%
    -1.84
    114.95%
    -1.88
    2.08%
    -0.44
    76.75%
    -0.90
    105.83%
    -0.39
    56.57%
    -0.11
    70.96%
    -0.75
    557.59%
    -0.97
    29.51%
    total debt to capitalization
    0.01
    -
    0.01
    47.26%
    0.01
    26.64%
    0.08
    990.80%
    0.01
    85.53%

    All numbers in USD (except ratios and percentages)